Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Soft pulls are typically monitored during underwriting. Align your credit health and income data to smooth the process.
13,406 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
As AI data centers surge, the choice between Constellation Energy and Vistra hinges on reliability, cost, and market ...
Oil stocks COP and Diamondback Energy offer very different risk-and-reward profiles. This guide breaks down cash flow...
A new House bill would ban lawmakers and their households from wagering in political prediction markets. The measure ...
When celebrity headlines grab attention, your finances should stay steady. This guide translates a moment in popular ...
A long-standing IRS provision lets parents transfer tuition and certain medical payments directly to institutions wit...
A major fund reduced its TransAlta stake in Q4, sparking questions about the stock’s trajectory. This article explain...
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
A notable stake increase in Shift4 Payments hints at growing conviction from Maestria Partners. This deep dive explai...
When a lockup period ends, insiders can sell their shares, creating potential price swings. This article breaks down ...
A new wave of AI infrastructure spending from Meta Platforms is shaping the outlook for Nvidia and the cloud ecosyste...
Two consumer-facing stocks sit at a crossroads: GameStop is tightening its turnaround with a leaner footprint, while ...